Galderma begins trading in the Swiss Market Index, joining Switzerland's leading blue chip companies Press release
Galderma’s Restylane® Volyme™ demonstrates high effectiveness, satisfaction and a robust safety profile in Chinese patients with temple hollowing Press release
Galderma receives European Union approval for Restylane® Shaype™: the first-and-only bone-mimicking hyaluronic acid injectable for facial shaping Press release
Galderma expands Cetaphil's Nourishing Line with new body care innovations, delivering clinically proven glow through advanced barrier science Press release
Galderma reports record first half 2026 net sales of 3.134 billion USD and 24.6% year-on-year growth at constant currency, raises net sales guidance for the full year Press release
Galderma launches Alastin® in Japan and key markets across Asia Pacific, expanding its footprint in the region Press release
Landmark global Galderma survey shows 9 out of 10 people are affected by skin quality concerns Press release
Galderma provides progress update regarding RelabotulinumtoxinA regulatory submission in the United States Press release
Galderma unveils new global survey data exploring the evolving expectations and experiences of patients and healthcare professionals with anti-wrinkle treatments Press release
